96 related articles for article (PubMed ID: 16173974)
1. Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy.
Filosa A; Valgimigli L; Pedulli GF; Sapone A; Maggio A; Renda D; Scazzone C; Malizia R; Pitrolo L; Lo Pinto C; Borsellino Z; Cuccia L; Capra M; Canistro D; Broccoli M; Soleti A; Paolini M
Br J Haematol; 2005 Oct; 131(1):135-40. PubMed ID: 16173974
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant micronutrients in children with thalassaemia in Egypt.
Nasr MR; Ali S; Shaker M; Elgabry E
East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
4. Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
Chang HH; Chen MJ; Lu MY; Chern JP; Lu CY; Yang YL; Jou ST; Lin DT; Yang YS; Lin KH
BJOG; 2011 Jun; 118(7):825-31. PubMed ID: 21401854
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia.
Pfeifer WP; Degasperi GR; Almeida MT; Vercesi AE; Costa FF; Saad ST
Acta Haematol; 2008; 120(4):225-31. PubMed ID: 19218790
[TBL] [Abstract][Full Text] [Related]
6. Spermatozoal DNA damage in patients with B thalassaemia syndromes.
De Sanctis V; Perera D; Katz M; Fortini M; Gamberini MR
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():185-9. PubMed ID: 19337176
[TBL] [Abstract][Full Text] [Related]
7. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
[TBL] [Abstract][Full Text] [Related]
8. Protection of beta-thalassaemic erythrocytes from oxidative stress by propionyl carnitine.
Palmieri L; Ronca F; Malengo S; Bertelli A
Int J Tissue React; 1994; 16(3):121-9. PubMed ID: 7852033
[TBL] [Abstract][Full Text] [Related]
9. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
Kumar P; Jagannathan NR; Choudhry VP
J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
[TBL] [Abstract][Full Text] [Related]
10. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients.
Tsapas A; Vlachaki E; Christoforidis A; Sarigianni M; Bekiari E; Perifanis V; Tsapas V; Paletas K; Athanassiou-Metaxa M
Eur J Haematol; 2007 Dec; 79(6):526-30. PubMed ID: 17961176
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
Prus E; Fibach E
Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress and iron overload in Jordanian β-thalassemic children.
Abdalla MY; Fawzi M; Al-Maloul SR; El-Banna N; Tayyem RF; Ahmad IM
Hemoglobin; 2011; 35(1):67-79. PubMed ID: 21250883
[TBL] [Abstract][Full Text] [Related]
14. Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients.
Kuppusamy UR; Tan JA
West Indian Med J; 2011 Jan; 60(1):3-8. PubMed ID: 21809703
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone deficiency (GHD) in adult thalassaemic patients.
Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
17. Non cardiopatic and cardiopatic beta thalassemic patients: quantitative and qualitative cardiac iron deposition evaluation with MRI.
Macarini L; Marini S; Pietrapertosa A; Scardapane A; Ettorre GC
Radiol Med; 2005; 109(1-2):77-90. PubMed ID: 15729188
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major.
Incorvaia C; Parmeggiani F; Costagliola C; Perri P; D'Angelo S; Sebastiani A
Eye (Lond); 2003 Apr; 17(3):324-9. PubMed ID: 12724693
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
Christoforidis A; Lefkou E; Vlachaki E; Perifanis V; Tsatra I; Dogramatzi F; Athanassiou-Metaxa M
Ann Hematol; 2007 Nov; 86(11):837-41. PubMed ID: 17668208
[TBL] [Abstract][Full Text] [Related]
20. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
